loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 400922d8 1756 41ed Aa66 590eeeb0864d Applno 22185 Form Suspension Topical Dosage 0 064 0 005 - Drug Product Composition: (5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol

    Menu

    (5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 950,068Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22185 / DOSAGE - SUSPENSION;TOPICAL - 0.064%;0.005%

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETAMETHASONE DIPROPIONATE(UNII: 826Y60901U)
    (BETAMETHASONE DIPROPIONATE - UNII:826Y60901U)     		BETAMETHASONE DIPROPIONATE0.643mg in 1
    CALCIPOTRIENE(UNII: 143NQ3779B)
    (CALCIPOTRIENE - UNII:143NQ3779B)     		CALCIPOTRIENE50ug in 1

    Inactive Ingredients

    Ingredient Name
    Warner Chilcott (US), LLC
    HYDROGENATED CASTOR OIL(ZF94AP8MEY)
    MINERAL OIL(T5L8T28FGP)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.